BMRN Stock Analysis: Buy, Sell, or Hold?
BMRN - BioMarin Pharmaceuticals Inc
$53.55
0.67 (1.27%)
▲
5d:
-1.92%
30d:
-3.46%
90d:
-11.21%
HOLD
MODERATE Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Smart Money Accumulation
BMRN is down 5.2% this week, but smart money is accumulating calls. Top strike: $60 2026-07-17 with 1,495 OI. Call ratio: 74% View Scanner →
Strength: 5.0/10
Get Alerted When BMRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BMRN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BMRN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$125.68
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$78.04
31.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BMRN is currently trading at $53.55, which is considered slightly low relative to its 30-day fair value range of $53.39 to $55.57. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.1) compared to its historical average (9.7). Remarkably, the market is currently pricing in an annual earnings decline of 6.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BMRN is in a downtrend. The price is currently testing key support at $52.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BMRN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $90.62 (+69.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BMRN is in a downtrend. The price is currently testing key support at $52.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BMRN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $90.62 (+69.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$53.39 -
$55.57
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding BMRN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.2% below Wall St target ($90.62)
Trading Range Analysis
30-Day Trading Range
$53.39 -
$55.57
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$52.08
Resistance Level
$57.44
Current Trend
Downtrend
Technical data as of
May 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.05
Wall Street Target
$90.63
(+69.2%)
Revenue Growth (YoY)
2.8%
Earnings Growth (YoY)
-43.5%
Profit Margin
8.3%
Valuation Discount vs History
-6.0% cheaper
PE vs Historical
8.1 vs 9.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.0%
(market-implied from PE analysis)
1-Year Target
$50.34
(-6%)
2-Year Target
$47.32
(-12%)
3-Year Target
$44.48
(-17%)
3-Yr Target (if PE normalizes)
(PE: 8→10)
$53.60
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 35.3%)
$363.27
(+578%)
Base:
(SPY PE: 8.0, Growth: 35.3%)
$132.66
(+148%)
Bear:
(PE: 6.8, Growth: 35.3%)
$112.76
(+111%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 37.83 | Current EPS (TTM): $1.39
Bull Case
$115.68
(+116%)
Analyst growth 100.0%, PE expands to 41.6
Base Case
$105.16
(+96%)
Market implied 100.0%, PE stable at 37.8
Bear Case
$35.75
(-33%)
Severe decline -20.0%, PE contracts to 32.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.0 to 9.7
Stabilization Target:
$64.54
(+20.5%)
PE Expansion Potential:
+20.5%
Share & Embed Analysis
Last updated: May 14, 2026 9:46 AM ET
Data refreshes hourly during market hours. Next update: 10:46 AM
Data refreshes hourly during market hours. Next update: 10:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Charles Greg Guyer
SELL
16486 shares
2026-03-11
Gregory R Friberg
SELL
6326 shares
2026-02-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$104 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$127 | 59 HOLD |
Advanced BMRN Option Strategies
Professional options setups generated by AI based on today's BMRN price and gamma walls.
